The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Open accessAbstract
CCR5-Maraviroc Structure: The chemokine receptor CCR5, a G protein–coupled receptor best known as a co-receptor during HIV-1 infection, is important in a variety of physiological processes. Tan et al. (p. 1387 , published online 12 September; see the Perspective by Klasse ) now report the high-resolution crystal structure of CCR5 bound to the HIV-1 entry inhibitor, Maraviroc. The structure suggests that Maraviroc acts as a noncompetitive inhibitor by binding to a region of CCR5 that is distinct from the binding site of HIV-1 and chemokines. Comparison of the structure of CCR5 with the other HIV-1 co-receptor, the chemokine receptor CXCR4, provides insight into the co-receptor selectivity of the virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Self-citationGerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., et al. (2010) · Science · doi:10.1126/science.1197410 · Cited by 1,128
Self-citationStructure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Self-citationAbagyan, R., & Totrov, M. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1052 · Cited by 975
Crystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Self-citationFusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Self-citationStructures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
Huang, C.-C., Lam, S. N., Acharya, P., Tang, M., Xiang, S.-H., Hussan, S. S.-U., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., et al. (2007) · Science · doi:10.1126/science.1145373 · Cited by 416
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
CCR5 Binds Multiple CC-Chemokines: MCP-3 Acts as a Natural Antagonist
Blanpain, C., Migeotte, I., Lee, B., Vakili, J., Doranz, B. J., Govaerts, C., Vassart, G., Doms, R. W., & Parmentier, M. (1999) · Blood · doi:10.1182/blood.v94.6.1899 · Cited by 287
Speck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B., & Goldsmith, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.7136-7139.1997 · Cited by 275
Pharmacological modulation of chemokine receptor function
Scholten, D., Canals, M., Maussang, D., Roumen, L., Smit, M., Wijtmans, M., de Graaf, C., Vischer, H., & Leurs, R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01551.x · Cited by 248
Brelot, A., Heveker, N., Montes, M., & Alizon, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000776200 · Cited by 236
Structural Basis for Coreceptor Selectivity by The HIV Type 1 V3 Loop
Cardozo, T., Kimura, T., Philpott, S., Weiser, B., Burger, H., & Zolla-Pazner, S. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0130 · Cited by 168
Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C., Leener, A. D., Vassart, G., Doms, R. W., Proudfoot, A. E. J., & Parmentier, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205684200 · Cited by 157
Assessing chemokine co-receptor usage in HIV
Coakley, E. P. G., Petropoulos, C. J., & Whitcomb, J. M. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200502000-00003 · Cited by 151
Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
García‐Pérez, J., Rueda, P., Alcamı́, J., Rognan, D., Arenzana‐Seisdedos, F., Lagane, B., & Kellenberger, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279596 · Cited by 119
Stanfield, R. L., Górny, M. K., Zolla‐Pazner, S., & Wilson, I. A. (2006) · Journal of Virology · doi:10.1128/jvi.00205-06 · Cited by 110
Recognition of RANTES by Extracellular Parts of the CCR5 Receptor
Duma, L., Häußinger, D., Rogowski, M., Lusso, P., & Grzesiek, S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.040 · Cited by 103
Development of a Bulk Enabling Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist
Haycock-Lewandowski, S. J., Wilder, A., & Åhman, J. (2008) · Organic Process Research & Development · doi:10.1021/op8000614 · Cited by 93
New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection
García‐Pérez, J., Rueda, P., Staropoli, I., Kellenberger, E., Alcamı́, J., Arenzana‐Seisdedos, F., & Lagane, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168955 · Cited by 87
Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
Palani, A., & Tagat, J. R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060009x · Cited by 85
Muniz-Medina, V. M., Jones, S. A., Maglich, J. M., Galardi, C. M., Hollingsworth, R. E., Kazmierski, W. M., Ferris, R. G., EDELSTEIN, M. P., Chiswell, K., & Kenakin, T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052555 · Cited by 78
Basmaciogullari, S., Babcock, G. J., Ryk, D. V., Wojtowicz, W. M., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10791-10800.2002 · Cited by 78
Imamura, S., Ichikawa, T., Nishikawa, Y., Kanzaki, N., Takashima, K., Niwa, S., Iizawa, Y., Baba, M., & Sugihara, Y. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051034q · Cited by 74
Functional impact of HIV coreceptor-binding site mutations
Biscone, M. J., Miamidian, J. L., Muchiri, J. M., Baik, S., Lee, F.-H., Doms, R. W., & Reeves, J. D. (2006) · Virology · doi:10.1016/j.virol.2006.03.017 · Cited by 35
Cited by
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Subbaiah, M. A. M., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01215 · Cited by 710
Singh, K. D., & Karnik, S. S. (2020) · GPCRs · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 704
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
Metadata
- Authors
- Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L., Fenalti, G., Li, J., Zhang, W., Xie, X., Yang, H., Jiang, H., Cherezov, V., Liu, H., Stevens, R. C., Zhao, Q., & Wu, B.
- Venue
- Science
- Published
- 2013-09-20
- Volume
- 341
- Issue
- 6152
- Pages
- 1387-1390
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2146933058
- Cited by
- 712
- References
- 34
- FWCI
- 42.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.